Five studies were comprised of participants who were all equol producers (Table 8); two of the studies found statistically significant beneficial effects of the isoflavone interventions on risk factors of CHD (including LDL-C, high-sensitivity C-reactive protein, TAG, inflammatory gene expression) while four studies observed negligible effects. The gene discussed is CRP; the disease is coronary artery disorder.